BiomX Inc.
PHGE
$0.5501
$0.00330.60%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -10.24% | 29.24% | 72.24% | 50.79% | 19.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.51% | 28.33% | 61.49% | 35.05% | 57.95% |
| Operating Income | 22.51% | -28.33% | -61.49% | -35.05% | -57.95% |
| Income Before Tax | -234.83% | 55.79% | -164.30% | 222.08% | 169.90% |
| Income Tax Expenses | -60.00% | -80.00% | 200.00% | -- | -37.50% |
| Earnings from Continuing Operations | -235.03% | 55.80% | -164.31% | 221.96% | 169.74% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -235.03% | 55.80% | -164.31% | 221.96% | 169.74% |
| EBIT | 22.51% | -28.33% | -61.49% | -35.05% | -57.95% |
| EBITDA | 22.89% | -29.32% | -50.06% | -34.70% | -58.15% |
| EPS Basic | -240.94% | 85.04% | 12.01% | 123.73% | 111.00% |
| Normalized Basic EPS | -129.21% | 87.54% | 61.56% | 148.95% | 153.15% |
| EPS Diluted | 71.98% | 85.04% | 2.12% | 123.73% | 44.67% |
| Normalized Diluted EPS | -144.96% | 87.54% | 61.56% | 148.95% | 134.52% |
| Average Basic Shares Outstanding | 348.49% | 270.78% | 200.41% | 170.12% | 35.41% |
| Average Diluted Shares Outstanding | 191.24% | 270.78% | 200.41% | 170.12% | 108.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |